The purpose of this paper is, first, to describe the organization, sampling procedures, availability of samples/database, ethical considerations, and quality control program of the Northern Sweden Health and Disease Study Cohort. Secondly, some examples are given of studies on cardiovascular disease and diabetes with a focus on the biomarker programme. The cohort has been positioned as a national and international resource for scientific research.
Get full access to this article
View all access options for this article.
References
1.
Johansson J. , Hallmans G., Wikman Å., Biessy C., Riboli E., Kaaks R.Validation and calibration of food frequency questionnaire measurements in the Northern Sweden Health and Disease cohort . Public Health Nutrition2002; 5: 487 - 96.
2.
Johansson G. , Wikman Å., Åhren A-M., Hallmans G., Johansson I.Underreporting of energy intake in repeated 24-hour recalls related to gender, age, weight status, day of interview, educational level, reported food intake, smoking habits and area of living. Public Health Nutrition2001; 4: 919 - 27.
3.
Abbott A.Sweden sets ethical standards for use of genetic Biobanks. Nature1999; 400: 3.
4.
Nilsson A., Rose J.Sweden takes steps to protect tissue banks. Science1999; 286: 894.
5.
Stegmayr B., Asplund K., Kuulasmaa K., Rajakangas A-M., Thorvaldsen P., Tuomilehto J.Stroke incidence and mortality correlated to stroke risk factors in the WHO MONICA Project. An ecological study of 18 populations. Stroke1997; 28: 1367 - 74.
6.
Ögren B., Weinehall L., Stegmayr B., Boman K., Hallmans G., Wall S.What else adds to hypertension in predicting stroke? An incident case-referent study. J Intern Med2000; 248: 475 - 82.
7.
Ahmed E., Stegmayr B., Hallmans G., Weinehall L., Trifunovic J., Lefvert AKAnticardiolipin antibodies are not an independent risk factor for stroke. An incident case-referent study nested within the MONICA and Vasterbotten cohort project. Stroke2000; 31: 1289 - 93.
8.
Ahmed E., Stegmayr B., Hallmans G., Lefvert AKAutoantibodies against oxidatively modified LDL do not constitute a risk for stroke. Stroke1999; 30: 2541 - 6.
9.
Ahlbeck-Glader C., Stegmayr B., Boman J., Stenlund H., Weinehall L., Hallmans G., Dahlen GHChlamydia pneumoniae antibodies and high lipoprotein(a) levels do not predict ischemic cerebral infarctions. Results from a nested case-control study in Northern Sweden. Stroke1999; 30: 2013-18.
10.
Johansson L. , Jansson JH, Stegmayr B., Nilsson TK, Hallmans G., Boman K.Tissue plasminogen activator (tPA), plasminogen activator inhibitor-1 (PAI-1) complex as risk factor for the development of a first stroke. Stroke2000; 32: 26 - 32.
11.
Söderberg S. , Ahrén B., Stegmayr B., Johnson O., Wiklund P-G., Weinehall L., Hallmans G., Olsson T.Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort. Stroke1999; 30: 328 - 37.
12.
Lindahl B., Dinesen B., Eliasson M., Röder M, Hallmans G, Stegmayr B. High proinsulin levels precede first-ever stroke in a nondiabetic population. Stroke2000; 31: 2936 - 41.
13.
Weinehall L. , Johnson O., Jansson JH, Boman K., Huhtasaari F., Hallmans G., Dahlén GH, Wall S.Perceived health modifies the effect of biomedical risk factors in the prediction of acute myocardial infarction. An incident case-control study from Northern Sweden . J Intern Med1998; 243: 99 - 107.
14.
Dahlen GH, Weinehall L., Stenlund H., Jansson JH, Hallmans G., Huhtasaari F., Wall S.Lipoprotein(a) and cholesterol levels act synergistically and apolipoprotein A-I is protective for the incidence of primary acute myocardial infarction in middle-aged males. An incident case-control study from Sweden. J Intern Med1998; 244: 425 - 30.
15.
Thögersen AM , Jansson JH, Boman K., Nilsson TK, Weinehall L., Huhtasaari F., Hallmans G.High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Circulation1998; 98: 2241-7.
16.
Söderberg S. , Ahrén B., Jansson JH, Johnson O., Hallmans G., Asplund K., Olsson T.Leptin is associated with increased risk of myocardial infarction. J Intern Med1999; 246: 409 - 18.
17.
Lindahl B., Dinesen B., Eliasson M., Röder M., Jansson JH, Huhtasaari F., Hallmans G.High proinsulin concentration precedes acute myocardial infarction in a nondiabetic population. Metabolism1999 ; 48: 1197 - 1202.
18.
Thögersen AM , Nilsson TK, Dahlen G., Jansson J-H., Boman K., Huhtasaari F., Hallmans G.Homozygosity for the plasma homocyst(e)ine are not associated with greater than normal risk of a first myocardial infarction in Northern Sweden. Coron Artery Dis2001; 12: 85-90.
19.
Ross R.Atherosclerosis - an inflammatory disease. N Engl J Med1999; 340: 115 - 26.
20.
Hallgren CG , Hallmans G., Jansson J-H., Marklund S., Schütz A., Strömberg U., Vessby B., Skerfving S.Intake of fish and risk of myocardial infarction - roles of methylmercury and polyunsaturated fatty acids. Br J Nutr2001; 86: 397 - 404.
21.
Lindahl B.Lifestyle and health. The role of the insulin resistance syndrome in cardiovascular disease and diabetes. The effects of lifestyle intervention . Umeå University dissertations No 552, 1998.
22.
Rolandsson O., Hägg E., Hampe C., Sullivan Jr EP, Nilsson M., Jansson J-H., Hallmans G., Lernmark Å.Glutamate decarboxylase (GAD65) and tyrosine phosphatase-like protein (IA-2) autoantibodies index in a regional population is related to glucose intolerance and body mass index. Diabetologia1999; 42: 555 - 9.
23.
Rolandsson O., Hägg E., Nilsson M., Hallmans G., Lernmark Å.Prediction of diabetes by screening with body mass index, oral glucose tolerance test (OGTT) and islet cell autoantibodies in a regional population. J Intern Med2001 ; 2494, 2003: 279 - 88.
